Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Isolated Abdominal Motor Seizures of Mesial Parietal Origin: Epileptic Belly Dancing?

Lizarraga KJ, Serrano EA, Tornes L, Kanner AM, Lang AE.

Mov Disord Clin Pract. 2019 Apr 19;6(5):396-399. doi: 10.1002/mdc3.12762. eCollection 2019 Jun. No abstract available.

PMID:
31286010
2.

Neurobiologic properties of mood disorders may have an impact on epilepsy: Should this motivate neurologists to screen for this psychiatric comorbidity in these patients?

Ribot R, Kanner AM.

Epilepsy Behav. 2019 Jun 7. pii: S1525-5050(19)30054-X. doi: 10.1016/j.yebeh.2019.01.026. [Epub ahead of print] Review.

PMID:
31182393
3.

Obstacles in the treatment of common psychiatric comorbidities in patients with epilepsy: What is wrong with this picture?

Kanner AM.

Epilepsy Behav. 2019 May 21. pii: S1525-5050(19)30230-6. doi: 10.1016/j.yebeh.2019.03.013. [Epub ahead of print] Review.

PMID:
31126824
4.

Psychiatric comorbidities go unrecognized in patients with epilepsy: "You see what you know".

Lopez MR, Schachter SC, Kanner AM.

Epilepsy Behav. 2019 Apr 23. pii: S1525-5050(18)30911-9. doi: 10.1016/j.yebeh.2019.01.027. [Epub ahead of print]

PMID:
31027939
5.

Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Mesial Temporal Epilepsy: A Case Series Analysis of Outcomes and Complications at 2-Year Follow-Up.

Cajigas I, Kanner AM, Ribot R, Casabella AM, Mahavadi A, Jermakowicz W, Sur S, Millan C, Saporta A, Lowe M, Velez-Ruiz N, Rey G, Ibrahim GM, Ivan ME, Jagid JR.

World Neurosurg. 2019 Jun;126:e1121-e1129. doi: 10.1016/j.wneu.2019.03.057. Epub 2019 Mar 15.

PMID:
30880205
6.

Classification of paroxysmal events and the four-dimensional epilepsy classification system.

Lüders H, Vaca GF, Akamatsu N, Amina S, Arzimanoglou A, Baumgartner C, Benbadis SR, Bleasel A, Bermeo-Ovalle A, Bozorgi A, Carreño M, Devereaux M, Francione S, Losarcos NG, Hamer H, Holthausen H, Jamal-Omidi S, Kalamangalam G, Kanner AM, Knake S, Lacuey N, Lhatoo S, Lim SH, Londoño LV, Mani J, Matsumoto R, Miller JP, Noachtar S, Palmini A, Park J, Rosenow F, Shahid A, Schuele S, Steinhoff BJ, Ákos Szabó C, Tandon N, Terada K, Boas WVE, Widdess-Walsh P, Kahane P.

Epileptic Disord. 2019 Feb 1;21(1):1-29. doi: 10.1684/epd.2019.1033. Review.

PMID:
30782582
7.

Psychiatric complications after epilepsy surgery… but where are the psychiatrists?

Fasano RE, Kanner AM.

Epilepsy Behav. 2019 Jan 15. pii: S1525-5050(18)30991-0. doi: 10.1016/j.yebeh.2018.12.009. [Epub ahead of print] Review.

PMID:
30658895
8.

Bidirectional relations among common psychiatric and neurologic comorbidities and epilepsy: Do they have an impact on the course of the seizure disorder?

Kanner AM, Ribot R, Mazarati A.

Epilepsia Open. 2018 Nov 20;3(Suppl Suppl 2):210-219. doi: 10.1002/epi4.12278. eCollection 2018 Dec.

9.

Opsoclonus-myoclonus-encephalopathy induced by cefepime.

Lizarraga KJ, Heros DO, Adams D, Lang AE, Kanner AM.

J Neurol Sci. 2019 Jan 15;396:33-35. doi: 10.1016/j.jns.2018.10.028. Epub 2018 Nov 1. No abstract available.

PMID:
30412900
10.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):269-278. doi: 10.5698/1535-7597.18.4.269.

11.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):260-268. doi: 10.5698/1535-7597.18.4.260.

12.

Ablation dynamics during laser interstitial thermal therapy for mesiotemporal epilepsy.

Jermakowicz WJ, Cajigas I, Dan L, Guerra S, Sur S, D'Haese PF, Kanner AM, Jagid JR.

PLoS One. 2018 Jul 6;13(7):e0199190. doi: 10.1371/journal.pone.0199190. eCollection 2018.

13.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Erratum in: Neurology. 2018 Dec 11;91(24):1117.

PMID:
29898974
14.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13.

PMID:
29898971
15.

Depression in people with epilepsy: How much do Asian colleagues acknowledge it?

Asadi-Pooya AA, Kanemoto K, Kwon OY, Taniguchi G, Dong Z, Chinvarun Y, Yu HY, McGonigal A, Kanner AM, Park SP.

Seizure. 2018 Apr;57:45-49. doi: 10.1016/j.seizure.2018.03.012. Epub 2018 Mar 12. Review.

16.

Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders?

Kanner AM, Scharfman H, Jette N, Anagnostou E, Bernard C, Camfield C, Camfield P, Legg K, Dinstein I, Giacobbe P, Friedman A, Pohlmann-Eden B.

Epilepsy Behav. 2017 Dec;77:106-113. doi: 10.1016/j.yebeh.2017.09.014. Epub 2017 Oct 26.

PMID:
29107450
17.

Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Scharfman HE, Kanner AM, Friedman A, Blümcke I, Crocker CE, Cendes F, Diaz-Arrastia R, Förstl H, Fenton AA, Grace AA, Palop J, Morrison J, Nehlig A, Prasad A, Wilcox KS, Jette N, Pohlmann-Eden B.

Epilepsy Behav. 2018 Jan;78:302-312. doi: 10.1016/j.yebeh.2017.09.016. Epub 2017 Oct 31. Review.

18.

Visual Deficit From Laser Interstitial Thermal Therapy for Temporal Lobe Epilepsy: Anatomical Considerations.

Jermakowicz WJ, Ivan ME, Cajigas I, Ribot R, Jusue-Torres I, Desai MB, Ruiz A, D'Haese PF, Kanner AM, Jagid JR.

Oper Neurosurg (Hagerstown). 2017 Oct 1;13(5):627-633. doi: 10.1093/ons/opx029.

19.

Disconnection of hippocampal networks contributes to memory dysfunction in individuals with temporal lobe epilepsy.

Stoub TR, Chicharro AV, Grote CL, Kanner AM.

Hippocampus. 2019 May;29(5):451-457. doi: 10.1002/hipo.22800. Epub 2017 Sep 21.

PMID:
28888031
20.

Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?

Kanner AM.

Neurochem Res. 2017 Jul;42(7):2071-2076. doi: 10.1007/s11064-017-2331-8. Epub 2017 Jul 1. Review.

PMID:
28667464
21.

Educational needs of epileptologists regarding psychiatric comorbidities of the epilepsies: a descriptive quantitative survey.

Mula M, Cavalheiro E, Guekht A, Kanner AM, Lee HW, Özkara Ç, Thomson A, Wilson SJ.

Epileptic Disord. 2017 Jun 1;19(2):178-185. doi: 10.1684/epd.2017.0915.

22.

Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE.

Nogueira MH, Yasuda CL, Coan AC, Kanner AM, Cendes F.

Epilepsia. 2017 Jul;58(7):1268-1276. doi: 10.1111/epi.13781. Epub 2017 May 26.

23.

Psychiatric comorbidities in new onset epilepsy: Should they be always investigated?

Kanner AM.

Seizure. 2017 Jul;49:79-82. doi: 10.1016/j.seizure.2017.04.007. Epub 2017 Apr 14. Review.

24.

The relationship between mood disorder and insomnia depends on race in US veterans with epilepsy.

Ebong IM, Lopez MR, Kanner AM, Wallace DM.

Epilepsy Behav. 2017 May;70(Pt A):80-86. doi: 10.1016/j.yebeh.2017.02.004. Epub 2017 Apr 12.

PMID:
28411520
25.

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Ribot R, Ouyang B, Kanner AM.

Epilepsy Behav. 2017 May;70(Pt A):5-9. doi: 10.1016/j.yebeh.2017.02.032. Epub 2017 Apr 10.

PMID:
28407526
26.

Laser thermal ablation for mesiotemporal epilepsy: Analysis of ablation volumes and trajectories.

Jermakowicz WJ, Kanner AM, Sur S, Bermudez C, D'Haese PF, Kolcun JPG, Cajigas I, Li R, Millan C, Ribot R, Serrano EA, Velez N, Lowe MR, Rey GJ, Jagid JR.

Epilepsia. 2017 May;58(5):801-810. doi: 10.1111/epi.13715. Epub 2017 Feb 28.

27.

Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents.

Bathena SPR, Leppik IE, Kanner AM, Birnbaum AK.

Epilepsy Behav. 2017 Apr;69:116-120. doi: 10.1016/j.yebeh.2017.01.027. Epub 2017 Feb 24.

28.

Association Between Selective Serotonin-Reuptake Inhibitor Antidepressants and Increased Risk of Poststroke Epilepsy.

Kanner AM.

Mayo Clin Proc. 2017 Feb;92(2):179-181. doi: 10.1016/j.mayocp.2016.12.012. No abstract available.

PMID:
28160869
29.

Psychiatric comorbidities in epilepsy: Should they be considered in the classification of epileptic disorders?

Kanner AM.

Epilepsy Behav. 2016 Nov;64(Pt B):306-308. doi: 10.1016/j.yebeh.2016.06.040. Epub 2016 Nov 21. Review.

PMID:
27884642
30.

Psychosis of epilepsy: a multifaceted neuropsychiatric disorder.

Kanner AM, Rivas-Grajales AM.

CNS Spectr. 2016 Jun;21(3):247-57. doi: 10.1017/S1092852916000250. Review.

PMID:
27322691
31.

Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.

Kanner AM.

Epilepsy Behav. 2016 Aug;61:282-286. doi: 10.1016/j.yebeh.2016.03.022. Epub 2016 May 25. Review.

32.

Management of psychiatric and neurological comorbidities in epilepsy.

Kanner AM.

Nat Rev Neurol. 2016 Feb;12(2):106-16. doi: 10.1038/nrneurol.2015.243. Epub 2016 Jan 18. Review.

PMID:
26782334
33.

Delivery of epilepsy care to adults with intellectual and developmental disabilities.

Devinsky O, Asato M, Camfield P, Geller E, Kanner AM, Keller S, Kerr M, Kossoff EH, Lau H, Kothare S, Singh BK, Wirrell E.

Neurology. 2015 Oct 27;85(17):1512-21. doi: 10.1212/WNL.0000000000002060. Epub 2015 Sep 30. Review.

34.

Remember…there is more to epilepsy than seizures!

Kanner AM, Meador KJ.

Neurology. 2015 Sep 29;85(13):1094-5. doi: 10.1212/WNL.0000000000001985. Epub 2015 Sep 2. No abstract available.

PMID:
26333797
35.

Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA.

Epilepsy Curr. 2015 May-Jun;15(3):144-52. doi: 10.5698/1535-7597-15.3.144. No abstract available.

36.

The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understanding.

Pohlmann-Eden B, Aldenkamp A, Baker GA, Brandt C, Cendes F, Coras R, Crocker CE, Helmstaedter C, Jones-Gotman M, Kanner AM, Mazarati A, Mula M, Smith ML, Omisade A, Tellez-Zenteno J, Hermann BP.

Epilepsy Behav. 2015 Oct;51:199-209. doi: 10.1016/j.yebeh.2015.07.005. Epub 2015 Aug 24. Review.

PMID:
26291774
37.

Third International Congress on Epilepsy, Brain, and Mind: Part 2.

Rektor I, Schachter SC, Arya R, Arzy S, Braakman H, Brodie MJ, Brugger P, Chang BS, Guekht A, Hermann B, Hesdorffer DC, Jones-Gotman M, Kanner AM, Garcia-Larrea L, Mareš P, Mula M, Neufeld M, Risse GL, Ryvlin P, Seeck M, Tomson T, Korczyn AD.

Epilepsy Behav. 2015 Sep;50:138-59. doi: 10.1016/j.yebeh.2015.07.014. Epub 2015 Aug 8. Review.

38.

Recent treatment advances and novel therapeutic approaches in epilepsy.

Serrano E, Kanner AM.

F1000Prime Rep. 2015 May 26;7:61. doi: 10.12703/P7-61. eCollection 2015. Review.

39.

Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China.

Tong X, An D, Lan L, Zhou X, Zhang Q, Xiao F, Park SP, Kanemoto K, Kanner AM, Zhou D.

Epilepsy Behav. 2015 Jun;47:6-10. doi: 10.1016/j.yebeh.2015.03.012. Epub 2015 May 21.

PMID:
26004785
40.

Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA.

Neurology. 2015 Apr 21;84(16):1705-13. doi: 10.1212/WNL.0000000000001487.

41.

Quality of life and mood in patients with medically intractable epilepsy treated with targeted responsive neurostimulation.

Meador KJ, Kapur R, Loring DW, Kanner AM, Morrell MJ; RNS® System Pivotal Trial Investigators.

Epilepsy Behav. 2015 Apr;45:242-7. doi: 10.1016/j.yebeh.2015.01.012. Epub 2015 Mar 26.

42.
43.

Validation of the Hamilton Rating Scale for Depression in adults with epilepsy.

Mula M, Iudice A, La Neve A, Mazza M, Mazza S, Cantello R, Kanner AM.

Epilepsy Behav. 2014 Dec;41:122-5. doi: 10.1016/j.yebeh.2014.08.029. Epub 2014 Oct 16.

PMID:
25461202
44.

Some thoughts on 15 years of Epilepsy & behavior.

Kanner AM.

Epilepsy Behav. 2014 Nov;40:64. doi: 10.1016/j.yebeh.2014.09.063. Epub 2014 Oct 23. No abstract available.

PMID:
25453549
45.

Comments on Beyenburg S et al. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy & behavior 2005;7:161-171.

Kanner AM.

Epilepsy Behav. 2014 Nov;40:24-5. doi: 10.1016/j.yebeh.2014.09.070. Epub 2014 Oct 25. No abstract available.

PMID:
25453545
46.

Introduction to epilepsies: complexity and comorbidities.

Schachter SC, Garcia-Cairasco N, Kanner AM.

Epilepsy Behav. 2014 Sep;38:1-2. doi: 10.1016/j.yebeh.2014.06.035. Epub 2014 Sep 30. No abstract available.

PMID:
25260239
47.

Is depression associated with an increased risk of treatment-resistant epilepsy? Research strategies to investigate this question.

Kanner AM.

Epilepsy Behav. 2014 Sep;38:3-7. doi: 10.1016/j.yebeh.2014.06.027. Epub 2014 Sep 26. Review.

PMID:
25260238
48.

Is it time to train neurologists in the management of mood and anxiety disorders?

Kanner AM.

Epilepsy Behav. 2014 May;34:139-43. doi: 10.1016/j.yebeh.2014.02.029. No abstract available.

PMID:
24780394
49.

Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Kanner AM, Mazarati A, Koepp M.

Neurotherapeutics. 2014 Apr;11(2):358-72. doi: 10.1007/s13311-014-0271-4. Review.

50.

Screening of major depression in epilepsy: the Neurologic Depression Disorders Inventory in Epilepsy-Spanish version (Argentina).

Thomson AE, Calle A, Fontela ME, Yepez L, Muñoz Giacomelli F, Jáuregui A, Racosta JM, Kanner AM.

Epilepsia. 2014 Feb;55(2):331-4. doi: 10.1111/epi.12503.

Supplemental Content

Loading ...
Support Center